These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21691104)

  • 1. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery.
    Jansen PL; van Werven J; Aarts E; Berends F; Janssen I; Stoker J; Schaap FG
    Dig Dis; 2011; 29(1):48-51. PubMed ID: 21691104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects.
    Lips MA; de Groot GH; Berends FJ; Wiezer R; van Wagensveld BA; Swank DJ; Luijten A; van Dijk KW; Pijl H; Jansen PL; Schaap FG
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):862-70. PubMed ID: 24841294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
    Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S; Wang Q; Billington C; Connett J; Ahmed L; Inabnet W; Chua S; Ikramuddin S; Korner J
    Obes Surg; 2016 May; 26(5):957-65. PubMed ID: 26259981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study.
    De Giorgi S; Campos V; Egli L; Toepel U; Carrel G; Cariou B; Rainteau D; Schneiter P; Tappy L; Giusti V
    Clin Nutr; 2015 Oct; 34(5):911-7. PubMed ID: 25306425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial.
    Nemati R; Lu J; Dokpuang D; Booth M; Plank LD; Murphy R
    Obes Surg; 2018 Sep; 28(9):2672-2686. PubMed ID: 29987678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.
    Mazidi M; de Caravatto PP; Speakman JR; Cohen RV
    Obes Surg; 2017 Mar; 27(3):826-836. PubMed ID: 28091894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.
    Gerhard GS; Styer AM; Wood GC; Roesch SL; Petrick AT; Gabrielsen J; Strodel WE; Still CD; Argyropoulos G
    Diabetes Care; 2013 Jul; 36(7):1859-64. PubMed ID: 23801799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertical banded gastroplasty versus standard or distal Roux-en-Y gastric bypass based on specific selection criteria in the morbidly obese: preliminary results.
    Kalfarentzos F; Dimakopoulos A; Kehagias I; Loukidi A; Mead N
    Obes Surg; 1999 Oct; 9(5):433-42. PubMed ID: 10605899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.
    Stoeckli R; Chanda R; Langer I; Keller U
    Obes Res; 2004 Feb; 12(2):346-50. PubMed ID: 14981228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.
    Albaugh VL; Flynn CR; Cai S; Xiao Y; Tamboli RA; Abumrad NN
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1225-33. PubMed ID: 26196952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
    Maghsoodi N; Alaghband-Zadeh J; Cross GF; Werling M; Fändriks L; Docherty NG; Olbers T; Dew T; Sherwood RA; Vincent RP; le Roux CW
    Ann Clin Biochem; 2017 Jul; 54(4):495-500. PubMed ID: 27555664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
    Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
    Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.
    Ciangura C; Corigliano N; Basdevant A; Mouly S; Declèves X; Touraine P; Lloret-Linares C
    Contraception; 2011 Dec; 84(6):649-51. PubMed ID: 22078197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass.
    Nguyen NT; Varela E; Sabio A; Tran CL; Stamos M; Wilson SE
    J Am Coll Surg; 2006 Jul; 203(1):24-9. PubMed ID: 16798484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
    Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
    Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.